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Abstract: Insulin resistance is an abnormal physiological state that occurs when insulin from
pancreatic β-cells is unable to trigger a signal transduction pathway in target organs such as the liver,
muscles and adipose tissues. The loss of insulin sensitivity is generally associated with persistent
hyperglycemia (diabetes), hyperinsulinemia, fatty acids and/or lipid dysregulation which are often
prevalent under obesity conditions. Hence, insulin sensitizers are one class of drugs currently
employed to treat diabetes and associated metabolic disorders. A number of natural products that act
through multiple mechanisms have also been identified to enhance insulin sensitivity in target organs.
One group of such compounds that gained interest in recent years are the dietary anthocyanins.
Data from their in vitro, in vivo and clinical studies are scrutinized in this communication to show
their potential health benefit through ameliorating insulin resistance. Specific mechanism of action
ranging from targeting specific signal transduction receptors/enzymes to the general antioxidant
and anti-inflammatory mechanisms of insulin resistance are presented.
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1. Introduction
The World Health Organization’s (WHO) global obesity data show that, in 2014, more than
1.9 billion adults (18 years and older) were overweight, of which over 600 million were considered
obese [1]. These data correspond to the adult population as 39% overweight and 13% obese,
while 41 million children under the age of five in the same year were reported as either overweight or
obese. This disturbing figure has also been growing with epidemic proportion with obesity number
reported to be more than double from 1980 to 2014 [1]. Hand in hand with this fact, the global
statistical data for the major obesity associated disease, diabetes, in 2014 were 422 million, while its
prevalence has risen from 4.7% in 1980 to 8.5% in 2014 [2]. Today, diabetes is a major cause of disabilities
(e.g., blindness and limb amputation), other diseases (e.g., kidney failure and cardiovascular diseases
including heart attack and stroke) and death. In the latter case, the WHO estimate for the year 2012
was about 1.5 million deaths directly by diabetes and another 2.2 million deaths related to high blood
glucose [2].
Diabetes mellitus is a disorder characterized with persistent hyperglycemia in the blood resulting
from either deficiency in insulin secretion from pancreatic β cells and/or resistance to insulin. In the
case of type-1 diabetes (T1D), the underlying insulin deficiency is a result of pancreatic β-cells
destruction by autoimmune-mediated response, while type-2 diabetes (T2D) is mainly caused by
insulin resistance, although impaired insulin secretion and β-cell death may also be evident. In both
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diabetes types, hyperglycemia, if not adequately managed, could lead to significant damage to vital
organs but the emphasis of this communication lies on insulin resistance which is prevalent in T2D
and/or obesity.
Being the main source of energy to nearly all cells in our body, glucose concentrations in the
blood, its release from complex carbohydrates in the gut, as well as its transport and storage systems
are tightly regulated. Central to glucose metabolism is the secretion of insulin by pancreatic β cells
following the postprandial excess in the blood, leading to its mobilization and storage in target organs
such as the liver, muscles and adipose tissues. The effect of insulin in target organs is regulated
through a receptor-mediated signal transduction pathways that has been a great subject of research
in the last few decades both for physiological understanding of its action and as targets for novel
drugs. The binding of insulin with its membrane receptor triggers autophosphorylation followed by
intracellular protein substrates (insulin receptor substrate-1 and -2) phosphorylation. Several upstream
and downstream key players in its signal-transduction pathway have been identified including the
phosphoinositide 3-kinase (PI3K)/AKT pathway that is known to be involved in the translocation of
glucose transporter 4 (GLUT-4) from intracellular vesicles to the cell membrane [3,4]. Since GLUT-4 is
involved in glucose transport in muscles and adipose tissues, it is a major therapeutic target for T2D [5].
As explained in the following sections, the mitogen-activated protein kinase (MAPK), adenosine
monophosphate-activated protein kinase (AMPK) and the stress-activated c-Jun N-terminal kinase
(JNK) pathways are other important signaling key players in insulin action that may be targeted by
potential therapeutic agents [6,7].
If the insulin released from pancreatic β-cell failed to adequately bind or trigger the signal
transduction pathway that leads to its expected physiological response, a condition known as insulin
resistance is developed. A decrease in insulin effectiveness means that more and more insulin release
is required to achieve the normal control of glucose and other (e.g., lipids) metabolisms. Interestingly,
persistent hyperglycemia (diabetes), hyperinsulinemia, fatty acids dysregulation (e.g., hyperlipidemia)
can also lead to insulin resistance [4,8]. In this context, this review is addressing the potential insulin
resistance modulatory effect of dietary natural products collectively called anthocyanins. Furthermore,
this approach is clinically relevant, as drugs such as rosiglitazone and pioglitazone are used to treat
diabetes and/or insulin resistance through their agonistic effect on peroxisome proliferator activated
receptor-gamma (PPAR-γ) [9]. Many natural products that act through similar mechanism have also
been identified [10]. Considering the various side effects of the clinically useful anti-diabetic drugs,
the search for novel anti-diabetic agents from natural sources including multifunctional flavonoids is
currently gaining a lot of attention [11–14].
2. Chemical Diversity of Dietary Anthocyanins
Anthocyanins are a group of polyphenolic natural products that belong to a broad class of
secondary metabolites collectively called flavonoids. Structurally, flavonoids, composed of a 15-carbon
skeleton, derive from two distinct biosynthetic pathways: the shikimic acid pathway giving rise to
the C6-C3 cinamate derivatives and the C6 acetate derived precursors. The general structural feature
of flavonoids is shown in Figure 1 and characterized by two aromatic rings (ring A and B) joined
together by a three linking carbon chain that may form a third cyclic structure normally designated
as ring C. The most common structural diversity of flavonoids arises due to the presence or absence
of the 4-ketone functional group, C2-C3-double bond, oxygenation at C-3, attachment site of the
ring-B at the linking three-carbon (C-2, C-3 or C-4 positions), etc. The further source of flavonoids’
diversity is the number of hydroxyl substitutes at the two aromatic rings (A and B) and further O- or
C-glycosylation and O-acetylation/etherification. Anthocyanins exhibit extended conjugated double
bonds in all three rings, resulting from the flavylium ion or 2-phenylbenzopyrilium that give rise
to their intense color pigments (Figure 1). Anthocyanins do also possess sugar units attached to
the flavonoid skeleton, normally through O-linkage, and hence are water soluble. The flavonoid or
aglycone unit of anthocyanins is called the anthocyanidins, which may also be present in plants in
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unglycosylated forms. The most common anthocyanidins encountered in plants are the pelargonidin,
cyanidin, peonidin, delphinidin, petunidin and malvidin (Figure 1). Depending on the number of
hydroxyl groups, site of attachment of the sugar unit(s), type of sugar (e.g., arabinose, galactose,
glucose, rhamnose, and xylose frequently encountered), glycosidic linkage (α or β linkage) and
complexity of the sugars (mono-, di- and trisaccharide) diverse group of anthocyanins are known to
occur in plants. Most of the bioactive anthocyanins discussed in the following sections possess one
sugar unit mostly as 3-O-glycoside forms of arabinose (7), glucose (8), rhamnose (9) and galactose
(10) in their pyranoside forms (Figure 2). Diglycoside forms including rutinose (11), sambubiose (12),
and sophorose (13) are also common, while acylation with caffeic (14), ferulic (15) and malonic (16)
acids (Figure 2) are presented in the structural diversity of the bioactive anthocyanins (Table 1).
Nutrients 2017, 9, 1111 3 of 24 
 
of sugar (e.g., arabinose, galactose, glucose, rhamnose, and xylose frequently encountered), 
glycosidic linkage (α or β linkage) and complexity of the sugars (mono-, di- and trisaccharide) diverse 
group of anthocyanins are known to occur in plants. Most of the bioactive anthocyanins discussed in 
the following sections possess one sugar unit mostly as 3-O-glycoside forms of arabinose (7), glucose 
(8), rhamnose (9) and galactose (10) in their pyranoside forms (Figure 2). Diglycoside forms including 
rutinose (11), sambubiose (12), and sophorose (13) are also common, while acylation with caffeic (14), 
ferulic (15) and malonic (16) acids (Figure 2) are presented in the structural diversity of the bioactive 
anthocyanins (Table 1). 
Table 1. Structural diversity of anthocyanins with reported ameliorative effect on insulin resistance *. 
Compound Cyanidin Glycosides Compound Delphinidin, Pelargonidin and 
Peonidin Glycosides  
17 Cyanidin-3-O-arabinoside 26 Delphinidin-3-O-galactoside  
18 Cyanidin-3-O-galactoside 27 Delphinidin-3-O-glucoside 
19 Cyanidin-3-O-glucoside  28 
Delphinidin-3-O-sambubioside-5-O-
glucoside 
20 Cyanidin-3-O-glucosyl-
rutinoside  
29 Pelargonidin-3-O-galactoside  
21 Cyanidin-3-O-rutinoside 30 Pelargonidin-3-O-glucoside3 
22 Cyanidin-3-O-
sambubioside  
31 Pelargonidin-3-O-rutinoside 
23 Cyanidin-3-O-
sophoroside 
32 
Pelargonidin-3-O-(2-O-(6-O-(E-3-O-(β-
D-glucopyranosyl)caffeyl)-β-D-
glucopyranosyl)-6-O-E-caffeoyl-β-D-
glucopyranoside)-5-O-β-D-
glucopyranoside
24 Cyanidin-3,5-O-
diglucoside 
33 Peonidin-3-O-rutinoside 
25 Cyanidin-3-O-
malonylglucoside 
34 
Peonidin-3-O-(2-O-(6-O-E-feruloyl-β-
D-glucopyranosyl)-6-O-E-c ffeoyl-β-D-
glucopyranoside)-5-O-β-D-
glucopyranoside 
* The effect of these compounds on insul n re stance is summarized in Tables 2 and 3.  
O
OH
OH
HO
O
OH
OH
Quercetin                                                         Anthocyanidins
A
B
C
O+
OH
OH
HO
OH
R1
R2
    R1          R2           Name
1   H           H        Pelargonidin
2  OH        OH      Delphinidin
3  OH         H        Cyanidin
4  OMe      OH      Petunidin
5  OMe      H         Peonidin
6  OMe      OMe   Malvidin
2
4'
3'
2'
7
5
3
 
Figure 1. The common flavonoid skeleton as exemplified by quercetin and the anthcyandins. Figure 1. The common flavonoid skeleton as exemplified by quercetin and the anthcyandins.Nutrients 2017, 9, 1111 4 of 24 
 
7 L-Arabinopyranose
O
HO
OH
OH
OH O
HO
OH
OH
OH
OH
8 D-Glucopyranose
O
HO
OH
OH
OH
9 L-Rhamnopyranose
O
HO
OH
OH
OH
OH
10 D-Galactopyranose
O
OH
OH
OH
HO
O
O
OH
OH
OH
11 Rutinose
O
OH
OH
OH
HO
O O
OH
OHHO
12 Sambubiose
O
OH
OH
OH
HO
O O
OH
OHHO
OH
  13 ß-Sophorose
COOH
OH
OH
14 Caffeic acid
OH
O
HO
O
16 Malonic acid
COOH
OH
OCH3
15 Ferulic acid  
Figure 2. Common sugars and ester derivatives of anthocyanins discussed in this article. The linking 
position of the sugars with the flavonoid skeleton is shown in red. 
3. Natural Occurrence of Dietary Anthocyanins 
Being bright in coloration, ranging red, pink, purple and blue, anthocyanins are the principal 
components of pigmented plant parts such as flowers and fruits. Their functions to the plant that 
produce them include aiding pollination [15,16] and seed dispersal by attracting insects and other 
animals, while their antioxidant effects have been implicated to the plants survival, especially in UV 
prevalent high altitude environments [17]. Besides the different hydroxyl substitutions of the 
anthocyanidins skeleton giving rise to different colorations, anthocyanins could undergo chemical 
transformation depending on various pH conditions to give rise to variable colors. Understanding 
this natural properties of anthocyanins is thus important in maintaining their natural color and 
stability during industrial processing, storage and shelf-life of anthocyanin-rich foods and/or 
colorants [18,19]. This remarkable chemical diversity is generally manifested in the anthocyanin-rich 
fruits and vegetables. The recent interest in the blue, red and purple colored cereal products such as 
purple corn and red and black rice grains are also due to their anthocyanin content that are claimed 
to have a plethora of health benefits. The most common sources of dietary anthocyanins remain 
berries, including blackberries, bilberries, chokeberries, elderberries, cranberries and raspberries. 
Figure 2. Common sugars and ester derivatives o thocya ins di cussed in this article. The linking
position of the sugars with the flavonoid skeleton is shown in red.
Nutrients 2017, 9, 1111 4 of 22
Table 1. Structural diversity of anthocyanins with reported ameliorative effect on insulin resistance *.
Compound Cyanidin Glycosides Compound Delphinidin, Pelargonidin and Peonidin Glycosides
17 Cyanidin-3-O-arabinoside 26 Delphinidin-3-O-galactoside
18 Cyanidin-3-O-galactoside 27 Delphinidin-3-O-glucoside
19 Cyanidin-3-O-glucoside 28 Delphinidin-3-O-sambubioside-5-O-glucoside
20 Cyanidin-3-O-glucosyl-rutinoside 29 Pelargonidin-3-O-galactoside
21 Cyanidin-3-O-rutinoside 30 Pelargonidin-3-O-glucoside3
22 Cyanidin-3-O-sambubioside 31 Pelargonidin-3-O-rutinoside
23 Cyanidin-3-O-sophoroside 32 Pelargonidin-3-O-(2-O-(6-O-(E-3-O-(β-D-glucopyranosyl)caffeyl)-β-D-glucopyranosyl)-6-O-E-caffeoyl-β-D-glucopyranoside)-5-O-β-D-glucopyranoside
24 Cyanidin-3,5-O-diglucoside 33 Peonidin-3-O-rutinoside
25 Cyanidin-3-O-malonylglucoside 34 Peonidin-3-O-(2-O-(6-O-E-feruloyl-β-D-glucopyranosyl)-6-O-E-caffeoyl-β-D-glucopyranoside)-5-O-β-D-glucopyranoside
* The effect of these compounds on insulin resistance is summarized in Tables 2 and 3.
3. Natural Occurrence of Dietary Anthocyanins
Being bright in coloration, ranging red, pink, purple and blue, anthocyanins are the principal
components of pigmented plant parts such as flowers and fruits. Their functions to the plant that
produce them include aiding pollination [15,16] and seed dispersal by attracting insects and other
animals, while their antioxidant effects have been implicated to the plants survival, especially in
UV prevalent high altitude environments [17]. Besides the different hydroxyl substitutions of the
anthocyanidins skeleton giving rise to different colorations, anthocyanins could undergo chemical
transformation depending on various pH conditions to give rise to variable colors. Understanding this
natural properties of anthocyanins is thus important in maintaining their natural color and stability
during industrial processing, storage and shelf-life of anthocyanin-rich foods and/or colorants [18,19].
This remarkable chemical diversity is generally manifested in the anthocyanin-rich fruits and
vegetables. The recent interest in the blue, red and purple colored cereal products such as purple
corn and red and black rice grains are also due to their anthocyanin content that are claimed to have
a plethora of health benefits. The most common sources of dietary anthocyanins remain berries,
including blackberries, bilberries, chokeberries, elderberries, cranberries and raspberries. Many other
highly colored fruits such as black currant, cherry, grape, strawberry, colored cabbage, eggplant and
radish are also known to have high levels of anthocyanins. Some of these products such as the berries
and grapes are fermented to yield beverages that are also rich sources of anthocyanins. In the following
sections, some of these plants as a source of anthocyanins are scrutinized for their potential insulin
sensitizing effects in mammalian cells.
4. Dietary Anthocyanins and Insulin Sensitivity/Resistance
4.1. In Vitro Protective Activity: Insulin Resistance Diabetic/Obese Condition
A summary of few selected key findings showing the enzyme inhibitory activities and various
other effects in in vitro cell culture-based experiments are shown in Table 2. α-Glucosidase and
pancreatic α-amylase are the major targets of anthocyanins that undoubtedly contribute to their
anti-diabetic effects [20–38]. This means that anthocyanins share some common anti-diabetic
mechanism with drugs such as acarbose that target carbohydrate digestion in the gut thereby limiting
the availability of glucose released to the blood. The research findings so far appear to suggest
that anthocyanins such of the common cyanidin, plegonidin, delphinidin and petunidin glycosides
are effective carbohydrate digestive enzyme inhibitors. In addition, in vitro studies on cell culture
including in insulin resistance hepatocytes (HepG2 cells), human adipocytes such as the classical
3T3-L1 adipocytes, the rat liver cells including H4IIE cells, muscle cells such as L6 myotubes, rodent
pancreatic β-cells and satellite cells have been conducted to evaluate the potential of anthocyanins in
insulin resistance [39–48] (Table 2). It can be summarized from these reports that anthocyanins may
increase insulin sensitivity and glucose uptake in vital organs such as the muscles and adipose tissues
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and hence can ameliorate insulin resistance under diabetic condition. In addition, anthocyanins exert
positive effect on adipocytes cell culture by suppressing lipogenic factors [42,43].
Table 2. In vitro modulatory effects of anthocyanins against insulin resistance and diabetes.
Anthocyanins Plant Name and Part Used In Vitro Model/Activity References
Purified acylated anthocyanins: e.g., 32 Morning glory (red flower) α-Glucosidase/Enzyme inhibition [20]
6-O-Caffeoylsophorose of the diacylated
anthocyanin, 34
Fermented purple-fleshed sweet
potato α-Glucosidase/Enzyme inhibition [21]
Purified acylated anthocyanin: 22 but not 19
or cyanidin (3) Viburnum dilatatum fruits α-Glucosidase/Enzyme inhibition [22]
Anthocyanins 18, 19 and 24 Synthetic source α-Glucosidase and pancreatic
α-amylase/Enzyme inhibition [23]
Methanolic extracts and purified
anthocyanins: 24 as well as cyanidin (3)
Noble Muscadine grape - whole fruit
and skin
α-Glucosidase and pancreatic
lipase/Enzyme inhibition [24]
Anthocyanins enriched water extract Ipomoea batatas (purple sweet potato) α-Amylase and
α-glucosidase/Enzyme inhibition [25]
Aqueous ethanol (70%) extract containing 19,
21, 31 and 33 Pulp of Sweet cherry cultivars α-Glucosidase/Enzyme inhibition [26]
Ethanol extract Syzygium dessiflorum fruits α-Amylase/Enzyme inhibition [27]
Smoothies containing anthocyanins 19–21,
23 and 33
Fruits of sour cherry (Prunus cerasus,
Prunus persica, Prunus armeniaca and
plum)
α-Amylase and
α-glucosidase/Enzyme inhibition [28]
Aqueous extract Roselle (Hibiscus sabdarilfa) flowers α-Amylase and
α-glucosidase/Enzyme inhibition [29]
Methanol extract Aegle marmelos fruit pulp
α-Amylase and
α-glucosidase/Enzyme inhibition;
L6 rat skeletal muscle
cells/Increase glucose uptake
[30]
Aqueous and methanol extracts Strawberries fruits α-Amylase and
α-glucosidase/Enzyme inhibition [31]
Aqueous extract Brazilian strawberry cultivar (Fragariax ananassa)
α-Amylase and
α-glucosidase/Enzyme inhibition [32]
Aqueous extracts Red current, black current, red andgreen goose berries
α-Amylase and
α-glucosidase/Enzyme inhibition [33]
Aqueous, methanolic, and acetic acid
extracts; Major component are 17–19
black chokeberry (Aronia melanocarpa)
berries
α-Amylase and lipase/Enzyme
inhibition [34]
Aqueous and ethyl acetate extracts Serviceberry plant samples (leaves,twig and berries) α-Glucosidase/Enzyme inhibition [35]
Purified flavonoids including anthocyanins Standard chemicals α-Glucosidase/Enzyme inhibition [36]
Aqueous methanol extracts containing
anthocyanins (21, 24 and 31) Fig (Ficus carica) fruits
α-Amylase and
α-glucosidase/Enzyme inhibition [37]
Ethanol and methanol extracts and purified
anthocyanins: 19 and 22 Elderberries (Sambucus nigra)
α-Glucosidase and
α-amylase/Enzyme inhibition;
skeletal muscle cells/Stimulate
glucose uptake
[38]
Anthocyanin-rich formulation and purified
anthocyanin: 28 Maqui berry (Aristotelia chilensis)
H4IIE rat liver cells and L6
mycotubes/Decrease glucose
production, increase glucose
uptake and enhanced insulin
stimulated downregulation of
gluconeogenic enzyme,
glucose-6-phosphatase
[39]
Aqueos extract containing 19 and 25 Rutgers Scarlet Lettuce
H4IIE rat hepatoma
cells/Inhibition of glucose
production
[40]
Acidified ethanol extract and purified
anthocyanins: 19, 21 and 30 Mulberry (Morus alba)
HepG2 cells/Increase
glucose uptake [41]
Purified anthocyanin: 19 Standard reference
Human omental adipocytes and
3T3-L1 cells/Increase glucose
transport, GLUT4 membrane
translocation and insulin
sensitivity (insulin like activity);
[42]
Aqueous extract containing high
concentration of acylated cyanidin and
peonidin
Purple sweet potato
3T3-L1 adipocytes/Suppress
leptin secretion and expression of
lipogenic and inflammatory
factors; promoted lipolytic action
[43]
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Table 2. Cont.
Anthocyanins Plant Name and Part Used In Vitro Model/Activity References
Standardized extract containing
25% anthocyanins Bilberry
3T3-L1 cell line/Decrease
adipocyte differentiation via
insulin signaling pathway
[44]
Fermented Juice Lowbush blueberry fruits
Insulin sensitive cultured muscle
cells and adipocytes/Stimulate
glucose uptake; increase
insulin sensitivity
[45]
Ethanol extract Canadian lowbush blueberry(Vaccinium angustifolium) fruits
Replicating βTC-tet
cells/Increase proliferation [46]
Aqueous extract Eugenia jambolana seeds and pulp
Cultured Islets of Langerhans cells
of normal and diabetic
rats/Stimulate insulin release
[47]
Purified anthocyanins: 18, 19, 27 and 29 Cornus fruits (C. officinalis and C. mas)
Rodent pancreatic β-cells
(INS-1832/13)/Increased insulin
secretion and prevent
insulin resistance
[48]
A few studies on the structure–activity relationship (SAR) of anthocyanins with respect
to their anti-diabetic potential have been conducted. For instance, the intestinal α-glucosidase
and pancreatic α-amylase inhibition activity was found higher in cyanadin 3-O position
substituted with glucose or galactose. Among the entire tested cyanadin analog, the higher
activity was recorded in cyanidin-3-galactoside followed by cyanidin-3-glucoside, cyanidin and
cyanidin-3,5-di-O-glucoside [23]. It is interesting to see that C-3-O-substitution with glucose
increases the activity, while one more substitution of glucose at C-5-O-position decreases the
activity. In another SAR activity study, acylation of anthocyanins with caffeic or ferulic acid
was found to enhance α-glucosidase inhibitory effect [20]. On the other hand, methylation
and methoxylation drop the activity while the glucose substitution at 3-O-position increases the
α-glucosidase inhibition. Similar results were reported from other studies with a higher α-glucosidase
inhibition activity of cyanidin-3-sambubioside followed by cyanidin-3-glucoside and cyanidin [22].
In another study, fifteen anthocyanins were isolated from Cornus fruits and tested for insulin
secretion in rodent pancreatic β-cells. Among all the anthocyanins, the higher activity was
recorded for cyanidin-3-glucoside and delphinidin-3-O-glucoside as compared to their galactoside
or sambubioside substitution and thus with increasing number of hydroxyl groups in anthocyanin
B ring, insulin secretion also increases [48]. In addition, when rat adipocytes were tested with
anthocyanins-cyanidin-3-O-glucoside and cyanidin, a total of 633 genes were upregulated under
cyanidin-3-glucoside treatment as compared to 427 under cyanidin, which showed structural
differences attributes to the expression of different genes and thus leads to variable functional
responses [49,50].
4.2. In Vivo Protective Activity: Insulin Resistance Diabetic/Obese Condition
A vast numbers of in vivo protective activities of anthocyanins against insulin resistance diabetic
and obesity condition have been performed on insulin resistant diabetic obese animal model using
either anthocyanin rich extract or isolated compounds (Table 3). These include extracts from
fruits/berries, such as Cornus mas, Ficus benghalensis, mulberry, blueberry bilberry, Morus, grape,
Aronia berry, sweet orange, sweet cherry, etc. The isolated anthocyanin compounds such as cyanidin,
delphinidin and pelorgonidin glucosides were also tested for their in vivo activity. These compounds
along with anthocyanin rich extracts were found to be effective in ameliorating the insulin resistance
condition and also increase insulin sensitivity, decrease body weight gain and accumulation of
lipids [40,51–91]. Other than fruits/berries, anthocyanins extracted from purple corn, black rice and
black soybean have also been tested in vivo against insulin resistance diabetic and obesity conditions
and found to be effective (Table 2). These data along with the in vitro evidence presented in Table 2
suggest different mechanisms being responsible for the protective activity of these anthocyanins
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(Figure 3). The most relevant mechanisms postulated so far include, increasing GLUT-4 translocations,
activation of the AMPK and lipolytic enzymes, decreasing the serine phosphorylation of IRS-1
(insulin receptor substrate 1), downregulating retinol binding 4 expression, SREBP-1 (sterol regulatory
element-binding protein 1) mRNA level and inhibition of fatty acid and triglycerol synthesis enzyme
and lypogenic activity. These all played effective role in increasing insulin sensitivity and reverse
diabetic/obese condition (e.g., [41,63,67]).
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Figure 3. Underlying mechanism of anthocyani s a ai st insulin resistance associated with diabetes
and/or obesity. The decrease in insulin resistance and enhancement of insulin sensitivity by
anthocyanins in target organs have been shown to be mediated through activation of the AMPK
(adenosine monophosphate-activated protein kinase) and downregulated the serine phosphorylation
of IRS-1 (insulin receptor substrate 1), enhanced GLUT4 (glucose transporter 4) translocation by
increasing the activity of PPAR-γ (peroxisome proliferator activated receptor-gamma), lowering the
hs-CRP (high sensitivity C reactive protein) concentration, and reduction of retinol binding 4 (RBP4)
expression. The reduction of weight gain by anthocyanins is also reported through mechanisms
including reduction in the SREBP-1(sterol regulatory elem t-binding protein 1) mRNA level and
inhibiti n of f tty acid (FA) and triglycerol (TG) synthesis enzymes as well as downregulation of
lipogenic factors and upregulation of lipolytic enzymes.
Table 3. In vivo effects of anthocyanins against insulin resistance or diabetes/obesity.
Anthocyanins * Plant Name and Part Used Animal Model Anti-diabetic and/orAnti-obesity Activity References
Juice Acerola (Malpighia emarginata DC.) fruits Diabetic Wister rats
Reduction in blood glucose
level, cholesterol and
triglyceride
[51]
Juice Aronia melanocarpa Fruits Diabetic rat Lower glucose and lipid level [52]
Juice Aronia melanocarpa (black chokeberry) Obese mice underhigh fat diet Lower lipid level [53]
Athocyanin fractyion of
ethanol extract Berberis integerrima fruits
STZ-induced
diabetic rats
Reduce glucose level and
increase glycogen [54]
Juice containing 19 and 25 Blackberries (Rubus adenotrichos Schltdl.Cv. “vino”)
STZ-induced
diabetic rats
Decreases the levels of glucose,
triacylglycerols and cholesterol [55]
Anthocyanin rich fractions Black rice (Oryza sativa)
Rats fed high
fructose rich diet
for 4 weeks
Increase plasma insulin level
and insulin sensitivity; prevent
insulin resistance;
hypolipidemic effect
[56]
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Table 3. Cont.
Anthocyanins * Plant Name and Part Used Animal Model Anti-diabetic and/orAnti-obesity Activity References
Anthocyanin rich
preparation Black soybean seed coat
STZ induced
diabetic rats
Protect pancreatic tissue from
apoptosis, regulation of glucose
transport; prevent insulin
resistance; hypolipidemic effect
[57]
Anthocyanin rich
preparation Black soybean (Glycine max L.)
Rats fed with high
fat diet
Decrease body weight gain;
suppress weight gain in liver,
epidymal and perirenal fat pads;
improve lipid profile, serum
triglyceride and cholesterol level
[58]
Juice Blueberries Obese rodent fedwith high fat diet
Improve insulin resistance and
glucose tolerance [59–61]
Powder diet Blueberries
Obese and insulin
resistance mice fed
with 60% high fat
diet and 4%
blueberries
Lower plasma glucose; increase
insulin sensitivity; reduce
adipocyte cell death
[62]
Juice/Powder Blueberries Obese rodent
Decrease body weight gain and
lipid accumulation; increase
insulin sensitivity
[59,63,64]
Powder Blueberries Obese rat Anti-obesity effect; increaseglucose absorption [65]
Powder Blueberry Obese mice fedwith high fat diet
Decrease body weight and body
fat accumulation [66]
Powder Blueberry
Obesity prone rat
(Zucher fatty and
Zucker lean)
Reduces triglycerides, fasting
insulin; improve insulin
sensitivity
[60]
Extract (unknown) Blueberries (Vaccinium myrtillus) orBilberries (Vaccinium cyanococcus)
Type-2 diabetic
male KK-Aγ mice
Amloriate insulin sensitivity;
improve diabetic condition;
suppress glucose production
and lipid content in the liver
[67]
Methanol extract and
anthocyanin fraction Blueberry (Vaccinium angustifolium) Diabetic mice Hypoglycemic activity [68]
Powdered formulation or
juice
Blueberry, Black current, Concord grape,
Black raspberry and Maqui berry
Obese mice with
high fat diet Improve insulin sensitivity [69]
Fermented beverage Blueberry and blackberry Obese mice fedwith high fat diet
Reduce fasting blood glucose
level; prevent obesity [70]
Juice Blueberry and Mulberry Obese mice fedwith high fat diet
Decrease body weight gain and
serum cholesterol level; reduce
insulin resistance, lipid
accumulation and leptin
secretion
[64]
Powder Blueberry (Vaccinium ashei) Obese male miceunder high fat diet
Decrease serum glucose;
improve lipid profile [71]
Powder Blueberry Female mice fedwith high fat diet
Supplement prevent glucose
and insulin tolerance in obese
post-menopausal mice
[61]
Spraydried (CellBerry®) Chokeberry
Rats fed with high
fructose-rich diet
Reduce weight gain; modulate
insulin, adipogenic and
inflammatory signaling
pathways
[72]
Purified anthocyanins: 18,
29 and 26 Cornelian cherry (Cornus mas)
Obese and insulin
resistance mice fed
with high fat diet
Decrease body weight and
accumulation of lipids and
triglyceride in the liver; increase
insulin level; preserve islet
architecture
[73]
Ethanol extract and
purified anthocyanin:
derivatives of
pelargonidin glycoside
Bark of Ficus benghalensis Linn.
Alloxan-induced
diabetic dogs
and rats
Hypoglycemic effect; stimulate
insulin secretion [74,75]
Freeze-dried powder and
crude extract preparations Gamazumi (Viburnum dilatatum)
STZ-induced
hyperglycemic rats
Decrease plasma glucose level;
antioxidant activity [76]
Freeze dried Jabuticaba
peel containing 19 and 27 Jabuticaba (Myrciaria spp.) peel
Rats under high
fat diet
Increase glucose and insulin
tolerance; reduce serum insulin
resistance; increase HDL level
[77]
Anthocyanin fraction from
aqueous methanol (70%)
extract 28
Maqui berry (Aristotelia chilensis)
Hyperglycemic
obese mice fed
high fat diet
Improve fasting blood glucose
level and glucose tolerance [39]
Aqueous ethanol (50%)
extract containing 1, 19
and 21
Morus alba fruits Zucker diabeticfatty rats
Decrease glucose level; maintain
insulin level and β cell histology [78]
Juice predominantly
containg 19 and 21 Morus australis fruits
Obese and insulin
resistance mice fed
with high fat diet
Suppress weight gain and
insulin resistance; attenuate
lipid accumulation; lower the
size of adipocytes
[64]
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Table 3. Cont.
Anthocyanins * Plant Name and Part Used Animal Model Anti-diabetic and/orAnti-obesity Activity References
Aqueous ethanol (70%)
and the ethyl
acetate fraction
Mulberry (Morus alba L.) fruit STZ induceddiabetic mice Hypoglycemic effect [79]
Aqueous extract Mulberry (Morus alba L.) fruits Male Syriangolden hamster
Prevent obesity; reduce hepatic
lipogenesis, body weight gain
and fat accumulation
[80]
Acidified ethanol extract
containing 19 and 20 Mulberry (Morus alba L.) fruit
db/db
diabetic mice
β-cell protection; reverse
insulin resistance [41]
Aqueous ethanol
(70%) extract Mulberry root bark
STZ induced
diabetic rats
Reduces serum glucose and
lipid peroxides; increased
insulin level
[81]
Concentrated juice Plums Wistar fatty rats Reduce blood glucose; increaseinsulin sensitivity [82]
Methanol extract Pomegranate (Punica granatumLinn.) flowers
Zucker diabetic
fatty rats Decreases plasma glucose level [83,84]
Powder rich in 19 Purple corn
High fat diet
induced insulin
resistance mice
Reverse insulin resistance;
suppress weight gain and
hypertrophy of adipocytes
[85]
Purified anthocyanin: 19 Purple corn Diabetic KKA-γmice
Reduces blood glucose level;
enhance insulin sensitivity [86]
Purified anthocyanin: 34 Purple sweet potato Male SpragueDawley rats
Increase plasma insulin
sensitivity; decrease
α-glucosidase activity
[87]
Aqueous alcohol extracts
containing 25 Rutgers Scarlet Lettuce
High fat diet
induced obese mice
Improve glucose metabolism;
decrease total liver lipid [40]
Aqueos alcohol extract Sapindus mukorossi fruits STZ induceddiabetic rats
Decrease blood glucose level
and lipid level [88]
Aqueous and ethyl
acetate extracts
Serviceberry plant samples (leaves, twig
and berries)
Diet induced obese
and hyperglycemic
mice
Lower blood glucose; delay
absorption of carbohydrate;
inhibit intestinal α-glucosidase
activity
[35]
Purified anthocyanin: 20,
21 and 31 Sweet cherry (Prunus avium)
Male mice fed with
high fat diet
Prevent body weight gain;
reduces size of adipocytes;
decrease leptin secretion, serum
glucose triglyceride, total
cholesterol and low density
lipoprotein
[89]
Anthocyanin-enriched
juices and purified 19
Sweet orange (Citrus sinensis), Moro (a
blood orange)
Obese mice fed
with high fat diet
Improve glucose tolerance,
insulin sensitivity; reduce
hepatic accumulation of lipid
[90]
Freeze-dried Tart cherries Male rats Decrease fasting glucose level;increase plasma insulin level [91]
* The full list of compounds designated with bold numbers is presented in Table 1.
5. Clinical Study
A few clinical studies have been conducted on the effect of anthocyanins against insulin resistance
under diabetes and/or obesity conditions. In one study, for example, anthocyanins from bilberry
(Vaccinium myrtillus) and black current (Ribes nigrum) was tested in patients with type-2 diabetic
condition and shown to significantly decrease the serum LDL (low-density lipoprotein) cholesterol by
7.9%, triglycerides by 23.0% and increased HDL (high-density lipoprotein) cholesterol by 19.4% [92].
In addition, it lowered fasting plasma glucose by 8.5% and in homeostasis model assessment for insulin
resistance by 13% [93]. In another study, smoothie containing 22.5 g blueberry powder (50:50 mixture
of Vaccinium ashei and Vaccinium corymbosum) was taken twice daily for 6 weeks by obese and insulin
resistance patients. A 67% of patient showed an increased insulin sensitivity of at least 10% or greater as
compared to control [93]. A meta-analysis was conducted on 1997 female participants of age between
18 and 76 years on consumption of flavonoids and its subclass (flavanones, anthocyanins, flavon-3-ols,
polymeric flavonoids, flavanols, and flavones) was also calculated from food frequency questionnaires
using USDA (U.S. Department of Agriculture) database. A significant lowering effect on peripheral
insulin resistance was seen in women consuming higher anthocyanins and flavones-rich food [94].
A pilot study with 22 diabetic patients (14 women and 8 men) were employed by Esmaillzadeh [95]
to assess the potential cholesterol-lowering effect of patients consuming concentrated pomegranate
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40 g/day over a period of eight weeks. At the end of the eighth week, it was reported that a significant
reductions in total cholesterol and LDL-cholesterol without any change in the serum triacylglycerol
concentrations. In a similar experiment, Rashidi et al., [96] studied the effect of daily consumption
of 45 g concentrated pomegranate for 3 month in diabetic patients. Even though the cholesterol and
LDL concentrations on the treatment group was lower, a significant effect was not observed in what
appears to be a contradiction with the other studies (e.g., [95]).
Edirisinghe et al. [97] recruited 24 overweight adults to study effect of strawberry consumption
on high-carbohydrate, moderate-fat meal diet. In their placebo beverage controlled cross-over
study, they have shown that strawberry beverage could attenuate the postprandial inflammatory
response as demonstrated from the lower level of high-sensitivity C-reactive protein and interleukin-6
(IL-6) in the treatment group. The increased postprandial prevalence of pelargonidin sulfate and
pelargonidin-3-O-glucoside following consumption of strawberry also suggest the potential role of
anthocyanins in the observed biological activity. A further example of a small pilot study is on açaí
palm (Euterpe oleracea Mart.) where 10 overweight adults (BMI≥ 25 kg/m2 and≤ 30 kg/m2) took 100 g
açai pulp twice daily for 1 month [98]. The suppressive effect of this treatment on the postprandial
increase in plasma glucose following the standardized meal was reported [98].
Unfortunately, clinical studies demonstrating the true potential of anthocyanin supplementation
are far from complete. Those studied so far are carried out in a small number of subjects with no clear
standardization formula applied to the drug preparations. Beyond inconsistencies in the preparations
of the plant materials, dosing regimens and other clinical study parameters such as patient groups,
blinding, etc. are other issues that all need to be addressed in the future. In this connection, a growing
number of clinical trials on anthocyanins are being conducted (Table 4) and perhaps the discrepancies
between the tremendous potential benefit of these class of compounds in ameliorating insulin resistance
and tackling T2D/obesity observed in vitro and in vivo and that in humans will be resolved in the
very near future. A lot more work is therefore required to further validate the true clinical potential
of anthocyanins if we have to consider them as drugs—or potential benefits far more than medicinal
foods (see the general discussion section below).
Table 4. Current clinical trials on anthocyanins as potential therapy against insulin resistance and/or
diabetes/obesity.
Clinical Trial Identifier No. Objective Voluntary and Dose Status
NCT01245270
Single supplement of standardized bilberry
extract (36% w/w anthocyanins) modifies
glycemic response in persons with type-2
diabetes controlled by diet and lifestyle
8 male patients of age between 40 and
70 years with type-2 diabetes given a single
oral capsule of 0.47 g standardized
blueberry extract followed by a
polysaccharide drink in a double blind
cross over intervention
Completed
NCT01005420
The effect of anthocyanins in the form of
blueberry powder on enhancing insulin
sensitivity in insulin resistant and
obese human
37 male and female of age 20 years and
older taking 45 g of blueberry powder per
day as a smoothie
Completed
NCT02689765
Effect of purified anthocyanins from
bilberries and black currant on insulin
resistance, glucose and lipid
metabolism disorders
160 humans both male and female with
type-2 diabetes of age 40–75 years taking
two 80 mg anthocyanin capsule twice a day
for 24 weeks
Completed
NCT 01883401
Investigate the effect of low and high doses
of freeze-dried strawberries in
cardiovascular risk factor in subjects with
abnormal adiposity and dyslipidemia
60 male and female patients of age between
19 and 72 years were given 25 and 50 g of
dried strawberries
Completed
NCT 02340039 The acute effect of black currant and appleextract on postprandial glycemia
34 male and female patients of age between
20 and 60 years were given 600 mg of black
current anthocyanins and 600 mg of
apple polyphenols
Completed
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Clinical Trial Identifier No. Objective Voluntary and Dose Status
NCT 02650726
Effect of purified anthocyanins on high
density lipoprotein and endothelial
function in subjects with type-2 diabetes
80 male and female patients of age between
40 and 60 years were given daily dose of
320 mg anthocyanin for 24 weeks in a
randomized double blinded
placebo-controlled trial
Completed
NCT 01053793
A trial to measure the glycemic index and
polyphenol bioavailability of four different
varieties of potato
10 male and female patients of age between
18 and 50 years were given 50 g of cooked
purple, red, yellow and white potatoes
Completed
NCT 02317211
Effect of purified anthocyanins on oxidative
stress and glycemic control in subjects with
type-2 diabetes
70 patients of age between 25 and 65 years
were given 320 mg anthocyanin daily for
12 weeks in a randomized double blinded
placebo-controlled trial
Completed
NCT 01720511
Pilot study of the effect of purple rice on
glucose tolerance, serum lipid
and inflammation
10 male and female patients of age 18 years
and above were given one cup of rice into
their dishes and consumed at lunch and
dinner each day for 4 weeks (equivalent to
4 ounces of uncooked rice/day)
Completed
NCT O2035592
Dose dependent impact of blueberry
powder intake on insulin sensitivity
and resistance
144 male and female of age 50–74 years Active
NCT 02291250 Effect of black currant containinganthocyanins on glucose metabolism 16 obese male female of 21–70 age Recruiting
NCT02972996
Effect of blueberry consumption on
cardiometabolic prevention in type-2
diabetes patients
48 male patients of age between 45 and
75 years were given 22 g of blueberry
powder in a randomized experiment
Recruiting
NCT 03213288
The effect of bilberry fruit and black rice
derived anthocyanins on lipid status
in adults
50 male and female patients of age 45 years
and older were given 320 mg of
anthocyanins for 28 days
Recruiting
NCT 02940080
Effect of anthocyanins extracted from
purple potatoes on healthy study subjects
Postprandial glycaemia and insulinemia
20 male patients of age between 18 and
45 years were given 168 mg of
anthocyanins extracted from purple-flashed
potatoes added to steam-cooked mashed
potatoes in water
Recruiting
NCT 02291250 Effect of soft fruit on postprandialblood glucose
16 overweight male and female patients of
age between 21 and 70 years were given
black current (200 g) and green currant
(200 g)
Recruiting
NCT01180712 Study of oral anthocyanins oninsulin resistance
60 obese type-2 diabetic males of age
40–70 years taking 1.4 g of concentrate
blueberry extract in a hard gelatin capsule
administered thrice a day for 21 days
Recruiting
(NCT numbers refer to the source of www.clinicalTrails.gov).
6. General Summary and Conclusions
There appear to be overwhelming in vitro and in vivo, and few clinical studies data to suggest
that dietary anthocyanins could ameliorate insulin resistance and offer health benefits in diabetic
conditions. One of the key features of their pharmacological effects appear to be linked to multiple
mechanisms ranging from inhibiting carbohydrate digestion in the gut, pancreatic β-cell protection
and insulin secretion to enhancing insulin sensitivity in vital organs. As insulin resistance is closely
linked to obesity, some of the common mechanisms for anthocyanins effect on insulin resistance is
summarized below.
Inflammation has been established to be the best characterized link between obesity and insulin
resistance. In fact, obesity is regarded as a state of low-grade inflammation where pro-inflammatory
cytokines and chemokines are continually released by adipocytes and immune cells leading to the
recruitment and infiltration of macrophages and other leucocytes population. The upregulation of
inflammatory cytokines (mainly tumour necrosis factor (TNF)-α and IL-6) and their role in insulin
resistance has been established and in this connection, readers are directed to the various review articles
on the subject [99–102]. Through activation of the NF-κB pathway, these pro-inflammatory cytokines
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suppress the insulin signal transduction pathway including the PI3K-AKT pathway (also known as
the protein kinase B (PKB)) through which insulin mediates glucose uptake while gluconeogenesis is
inhibited. Likewise, an increase in the level of triglycerides is associated with insulin resistance through
the same mechanism. The other closely related insulin signaling pathway is the MAPK pathway which
together with the PI3K-AKT pathway initiate gene expression, cell growth and differentiation. Agents
that promote the phosphorylation of IRS1 (e.g., the serine kinases that phosphorylate serine 307) such as
the NF-κB and C-jun N-terminal kinase 1 (Jnk1) in the JNK/AP-1 pathway could diminish the insulin
response. Hence, in addition to the NF-κB through action on the IK-κB, cytokines and fatty triglycerides
that activate the ser/thr kinases such as Jun NH2-terminal kinase (JNK) and protein kinase C (PKC)
pathways suppress insulin signaling [100,101]. The known anti-inflammatory effect of anthocyanins
is therefore expected to play major role in their potential benefit in ameliorating insulin resistance.
In vivo experiments, for example, have shown that anthocyanins such as cyanidin-3-O-β-glucoside
can suppress monocyte infiltration [103] and have potential to treat lung inflammation [104] as well
as atherosclerosis-related diseases. At the molecular level, their mechanisms of anti-inflammatory
effect include inhibition of cyclooxygenase [105] and the MAPK and NF-κB signaling pathways [106].
Through the combined effect on reactive oxygen species (ROS) and NF-κB, the inhibitory effect of
anthocyanins and/or anthocyanidins have been reported [107], while other reports indicate direct
inhibitory effect on the expression of inflammatory genes [108]. Other studies also revealed that
anthocyanins (e.g., Mulberry anthocyanin extract) ameliorate insulin resistance in vitro by regulating
the PI3K/AKT pathway [109].
Along with inflammation, the role of oxidative stress in obesity and insulin resistance has been
the subject of intense debate in recent years. The growing body of evidence now suggests that
ROS generation under the state of obesity is upregulated while antioxidant defenses diminish over
time and this trend is even greater after the onset of diabetes. Hence, 3T3-L1 adipocytes lose their
sensitivity to insulin in vitro when exposed to H2O2 even in micromolar concentration range [110];
while insulin resistance in this cells induced by TNF-α could be reversed by boosting antioxidant
defenses [111] (e.g., β-carotene accumulation) suggesting the link between oxidative stress and
insulin resistance. Similarly, other natural products including fermented rice bran extract [112]
and green tea flavonoids (catechins) [113] have been shown to improve insulin resistance through
antioxidant mechanisms. Undoubtedly, one of by far the most common mechanisms involved
in the health benefit of anthocyanins including in insulin resistance is therefore related to their
proven antioxidant effects. As with other flavonoids, the phenolics nature of these compound
accounts to the antioxidant effects but their optimal structure of the catechol functional group is
the key determinant that we have shown to play pivotal role for the antioxidant potential of natural
products [14,114–127]. The numerous hydroxyl positions of the flavonoid skeleton coupled with
the fully extended double bonds including in the C-ring play important in the free radicals and/or
ROS scavenging properties of anthocyanins. Accordingly, cyanidin-3-O-β-D-glucoside and related
anthocyanins have been demonstrated to protect macromolecules including DNA from oxidative
damage [128–130] or cellular damage induced in vitro by ROS [131]. Organoprotective effects such as
the heart in the ischemia-reperfusion injury [132] have also been shown for anthocyanins. In addition
to direct scavenging effect, the generation of ROS induced by various agents has been shown
to be suppressed by anthocyanins including cyanidin-3-O-β-glucopyranoside [133]. As expected,
the aglycones of anthocyanins also possess antioxidant effects as well as protective ability in animal
cells against oxidative injury and/or cell death [134,135]. Anthocyanins have also been shown to
induce phase II enzymes through the antioxidant response element pathway [136]. Animal models
of diabetes also revealed that anthocyanins (boysenberry anthocyanins) inhibit oxidative stress by
increasing the level of glutathione [137], while other similar studies have shown an increase in
the level of antioxidant enzymes such as catalase, superoxide dismutase (SOD), and glutathione
peroxidase (GPx) [138]. Hence, the overall antioxidant effects of anthocyanins could be mediated
both through direct effect on ROS generation and/or scavenging and enhancement of antioxidant
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defenses. Considering the deletion of pancreatic β-cells involve oxidative mechanism and the later
stage of diabetes complications such as the glucose oxidation-induced damage and cardiovascular
problems are closely linked to oxidative stress, antioxidant mechanism of anthocyanins could offer a lot
more health benefits than just enhancing inulin sensitivity. In this regard, the direct β-cell protective
effects of anthocyanins, such as those from blueberries and cyanidin-3-O-glucoside isolated from
mulberry fruit, have been well documented [92,139]. On the other hand, the hyperglycemia-induced
formation of advanced glycation end products that is correlated to oxidative stress associated with
diabetic complication has to be overcome through antioxidant therapy. The demonstration of dietary
anthocyanins in diabetes treatment as evidenced from various studies including anthocyanin-rich
extract from black rice [56] and numerous others highlighted in Tables 2 and 3 are classical example of
potential dietary intervention of insulin resistance by these group of natural products.
One of the well-established mechanism of anti-diabetic drugs is through upregulation
of expression of the glucose transporter GLUT-4 that anthocyanins have been shown to be
effective. For example, the amelioration of insulin resistance and anti-diabetic effects in the
streptozotocin-induced diabetic rat model by anthocyanins has been shown to be coupled with
GLUT-4 regulation [59]. The AMPK pathway has also been emerged as a major drug target for diabetes
and related diseases given its crucial regulatory role in energy metabolism involving glucose and
lipids [140]. The increased phosphorylation of the AMPK pathway by anthocyanin such as those from
mulberry fruit extract could not only increase glucose uptake but also inhibit gluconeogenesis and
stimulates glycogen synthesis [141]. The improvement of glucose homeostasis in diabetic mice by
cyanidin-3-O-β-glucoside [142] and dietary anthocyanin-rich bilberry extract [67] has been shown
to be mediated through activation of the AMPK pathway. The study by Huang et al. [143] on the
anti-diabetic effect of purple corn extract on C57BL/KsJ db/db mice model also shed some light on the
involvement of the AMPK pathway in the anti-diabetic potential of anthocyanins. The study revealed
that purple corn extract increased the phosphorylation of AMPK and decreased phosphoenolpyruvate
carboxykinase, glucose 6-phosphatase genes in liver, while the GLUT4 expressions in skeletal muscle
was augmented. These activities were coupled with anti-diabetic effect as assessed by reduction in the
fasting glucose level and HbA1c levels. Hence, the interlinking role of oxidative stress and the AMPK
pathway in glucose metabolism and diabetes control by anthocyanins is a proven productive area of
interest that gained momentum in recent years [41,144].
Another mechanism for anthocyanin’s health benefit is through effects on the various functional
aspects of adipocytes that is linked to insulin resistance. Anthocyanin extracts from black soybeans,
which were shown to be composed of cyanidine-3-O-glucoside (68.3%), delphinidin-3-O-glucoside
(25.2%), and petunidin-3-O-glucoside (6.5%), not only reduced lipid accumulation in vitro but also
suppressed the expression of the PPAR-γ [145]. Given that the thiazolidinediones (TZD) classes
of anti-diabetic drugs are effectively used due to they being the PPAR ligands through which they
initiate adipocytes genes activation and cellular differentiation, the effect of anthocyanins on this
system is another interesting dimension of diverse mechanisms. Anthocyanins could also lower
the level of circulating free fatty acids through direct effect on lipolysis in adipose tissue. In this
regard, cyanidin-3-O-β-glucoside has been shown to suppress the expression of adipose triglyceride
lipase in cultured 3T3-L1 adipocytes while at the same time increasing the activity of the AMPK [146].
One more adipocyte regulator that gained interest in recent years has been the retinol binding protein
4 (RBP4) which by its own right can be classified as an adipocytokine. The level of RBP4 in the blood
and adipose tissue appears to be increased in obesity and/or diabetes. The correlation between this
dysregulation and development of insulin resistance has been reviewed (e.g., [147–149]). Interestingly,
anthocyanin (e.g., cyanidin-3-O-glucoside) have been shown to downregulate the RBP4 in the white
adipose tissue in type 2 diabetic mice while at the same time upregulating the GLUT-4 and suppressed
adipocytokines (monocyte chemoattractant protein-1 and tumor necrosis factor-α) [86].
Given the diverse mechanism of action of anthocyanins that is implicated in tackling various
disease conditions, their absorption and pharmacokinetic profile have also been scrutinized in recent
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years. Anthocyanins appear to be absorbed throughout the gut including in the stomach (e.g., [150])
and the colon [151]. Being glycosides, they appear to exploit the glucose transport systems (GLUT-1/2)
in the small intestine and extensive research articles describing the detailed mechanisms have been
published [152–155]. These studies suggest that intact anthocyanins are absorbed from the ilium and
reach to vital organs such as the liver, blood, kidney and ocular tissues while other derivatives such as
the common glucoronate and methylated products are also common [156–158]. Anthocyanins can also
be converted by the gut microbiota into other smaller products such as aromatic acids, which could
also contribute to their known pharmacological effects (e.g., [159–162]).
In conclusion, dietary anthocyanins appear to be targeting insulin sensitivity through diverse
mechanisms and have potential to modulate disease states like diabetes. Their modulatory effect in
insulin resistance appears to be mediated via targeting the various specific insulin signal transduction
pathways of enzymes/receptors and also through general antioxidant and anti-inflammatory
mechanisms. With respect to them being used as medicine by their own right, comprehensive clinical
studies with standardized anthocyanins components, doses, blinding and large number of subjects
need to be performed to ascertain their true therapeutic potential for treating diabetes and associated
diseases. In the meantime, their dietary benefits appear to be extended to enhancing insulin sensitivity
that is often linked to obesity and the development of diabetes. In this regard, their multifunctional
nature, expressed in our title, when food become a medicine, is a well-deserved statement that begs
for further studies on these promising natural products.
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